Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (107)	3/5/1998 5:53:00 PM
From: Mike Sesan	Read Replies (1) \| Respond to of 3044

I have traded this stock since December 1997. It has good support around Low $17.00 and resistance around $22.00. Back in December it dipped as far as $16.00. It has traded two cycles since then from 16.00 to $21.00+ then back to about $17.50 then back to $22.00. People speculating on the positive earnings side kept people in for the hold then we I took profit. I believe in the company but my concern is when they got their patent approved the stock did not move upward. I question the amount of institutional support as to why big blocks were not bought when this occurred. I probably would buy again but need to see where this support level holds.

To: John O'Neill who wrote (107)	3/7/1998 6:58:00 PM
From: Richard Haugland	Read Replies (2) \| Respond to of 3044

Unfortunately I did not get my $22-23 at which I could sell MLNM so I rode it back down, where I have bought and sold some twice in the past two days for small profits. Still have my core holdings at a profit. Given the number of "strong buy" ratings, either the stock will be a phenom or can only go down. However, my overall hope is that the whole field of genomics will find strong support soon. There are some incredible things being done out there. Perhaps the cover of Time Magazine would help.